OTCMKTS:SMMNY Siemens Healthineers (SMMNY) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free SMMNY Stock Alerts $27.03 -0.62 (-2.24%) (As of 04/18/2024 ET) Add Compare Share Share Today's Range$26.98▼$27.2850-Day Range$27.03▼$31.4752-Week Range$23.80▼$31.92Volume31,312 shsAverage Volume87,338 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort Interest Get Siemens Healthineers alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Siemens Healthineers Stock (OTCMKTS:SMMNY)Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.Read More SMMNY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SMMNY Stock News HeadlinesApril 15, 2024 | americanbankingnews.comShort Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Grows By 33.3%April 5, 2024 | nasdaq.comGeneral Electric: A Legacy Splits into Three for Growth (SMMNY)April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.March 31, 2024 | finance.yahoo.comSiemens Healthineers AG (SMMNY)March 21, 2024 | msn.comSiemens Healthineers closes fast track testing armMarch 19, 2024 | msn.comSiemens to help boost PH health care sectorJanuary 7, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Siemens Healthineers AG (OtherSEMHF), Qiagen (QGEN) and Medios AG (OtherMEDOF)January 5, 2024 | realmoney.thestreet.comSiemens Healthineers price target lowered by EUR 0.50 at BarclaysApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.November 19, 2023 | morningstar.comSiemens Healthineers AG ADR SMMNYNovember 15, 2023 | seekingalpha.comSMMNY Siemens Healthineers AGNovember 13, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Siemens Healthineers AG (OtherSEMHF) and Mirum Pharmaceuticals (MIRM)November 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Calliditas Therapeutics (CALT), Siemens Healthineers AG (OtherSEMHF) and Demant (OtherWILLF)November 8, 2023 | markets.businessinsider.comBarclays Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)November 2, 2023 | msn.comSiemens Healthineers Weighs Options for Diagnostics ArmNovember 2, 2023 | msn.comSiemens Healthineers said to be evaluating options for diagnostics unitOctober 25, 2023 | stockhouse.comSiemens Healthineers picks RISE with SAP to Boost PerformanceSeptember 30, 2023 | markets.businessinsider.comKepler Capital Sticks to Their Hold Rating for Siemens Healthineers AG (SEMHF)September 24, 2023 | fool.comSiemens Healthineers Ag (OTC: SMMNY)August 20, 2023 | bbc.comTurning the tide on non-alcoholic fatty liver diseaseAugust 3, 2023 | markets.businessinsider.comSiemens Healthineers AG (SEMHF) Gets a Hold from Kepler CapitalJuly 20, 2023 | finance.yahoo.comSiemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challengesJuly 13, 2023 | reuters.comSiemens to spend 1 bln euro in Germany as Berlin warns about ChinaJune 21, 2023 | markets.businessinsider.comBarclays Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)June 15, 2023 | markets.businessinsider.comSiemens Plans Investments In Manufacturing Capacity Expansion - Quick FactsJune 15, 2023 | msn.comSiemens to invest €2B to boost manufacturing; AI, metaverse part of ~€500M R&DMay 19, 2023 | markets.businessinsider.comBerenberg Bank Remains a Buy on Siemens Healthineers AG (SEMHF)See More Headlines Receive SMMNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/19/2024Ex-Dividend for 5/7 Dividend4/19/2024Dividend Payable5/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:SMMNY CUSIPN/A CIKN/A Webwww.healthcare.siemens.de Phone(949) 913-1840FaxN/AEmployees71,400Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Bernhard Montag (Age 55)President, CEO & Chairman of Management Board Comp: $3.41MDr. Jochen Schmitz Ph.D. (Age 58)CFO & Member of Management Board Comp: $2.02MMs. Darleen Caron (Age 60)Chief Human Resources Officer, Labor Director & Member of Management Board Comp: $1.8MMs. Elisabeth Staudinger-Leibrecht (Age 54)Member of Management Board Comp: $1.25MMr. Marc KoebernickHead of Investor RelationsChristian KlaussnerExecutive Vice President of FinanceAndre HartungHead of ImagingCarsten BertramHead of Advanced TherapiesMs. Sharon J. Bracken (Age 53)Head of Diagnostics Jerry WangHead of ChinaMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors SMMNY Stock Analysis - Frequently Asked Questions Should I buy or sell Siemens Healthineers stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SMMNY shares. View SMMNY analyst ratings or view top-rated stocks. How have SMMNY shares performed in 2024? Siemens Healthineers' stock was trading at $29.13 at the beginning of the year. Since then, SMMNY stock has decreased by 7.2% and is now trading at $27.0325. View the best growth stocks for 2024 here. Are investors shorting Siemens Healthineers? Siemens Healthineers saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 800 shares, an increase of 33.3% from the March 15th total of 600 shares. Based on an average daily volume of 165,500 shares, the days-to-cover ratio is presently 0.0 days. View Siemens Healthineers' Short Interest. How often does Siemens Healthineers pay dividends? What is the dividend yield for Siemens Healthineers? Siemens Healthineers declared a dividend on Saturday, March 23rd. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.3102 per share on Tuesday, May 7th. The ex-dividend date of this dividend is Friday, April 19th. Read our dividend analysis for SMMNY. Is Siemens Healthineers a good dividend stock? Siemens Healthineers (OTCMKTS:SMMNY) pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for SMMNY. How do I buy shares of Siemens Healthineers? Shares of SMMNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SMMNY) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Siemens Healthineers AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.